• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类自然杀伤细胞抑制性受体KIR2DL1-HLA-Cw4复合物的晶体结构

Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex.

作者信息

Fan Q R, Long E O, Wiley D C

机构信息

Department of Molecular and Cellular Biology and Howard Hughes Medical Institute, Harvard University, 7 Divinity Avenue, Cambridge, MA 02138, USA.

出版信息

Nat Immunol. 2001 May;2(5):452-60. doi: 10.1038/87766.

DOI:10.1038/87766
PMID:11323700
Abstract

Inhibitory natural killer (NK) cell receptors down-regulate the cytotoxicity of NK cells upon recognition of specific class I major histocompatibility complex (MHC) molecules on target cells. We report here the crystal structure of the inhibitory human killer cell immunoglobulin-like receptor 2DL1 (KIR2DL1) bound to its class I MHC ligand, HLA-Cw4. The KIR2DL1-HLA-Cw4 interface exhibits charge and shape complementarity. Specificity is mediated by a pocket in KIR2DL1 that hosts the Lys80 residue of HLA-Cw4. Many residues conserved in HLA-C and in KIR2DL receptors make different interactions in KIR2DL1-HLA-Cw4 and in a previously reported KIR2DL2-HLA-Cw3 complex. A dimeric aggregate of KIR-HLA-C complexes was observed in one KIR2DL1-HLA-Cw4 crystal. Most of the amino acids that differ between human and chimpanzee KIRs with HLA-C specificities form solvent-accessible clusters outside the KIR-HLA interface, which suggests undiscovered interactions by KIRs.

摘要

抑制性自然杀伤(NK)细胞受体在识别靶细胞上特定的I类主要组织相容性复合体(MHC)分子后会下调NK细胞的细胞毒性。我们在此报告了与I类MHC配体HLA-Cw4结合的抑制性人类杀伤细胞免疫球蛋白样受体2DL1(KIR2DL1)的晶体结构。KIR2DL1-HLA-Cw4界面表现出电荷和形状互补性。特异性由KIR2DL1中的一个口袋介导,该口袋容纳HLA-Cw4的Lys80残基。HLA-C和KIR2DL受体中保守的许多残基在KIR2DL1-HLA-Cw4和先前报道的KIR2DL2-HLA-Cw3复合物中形成不同的相互作用。在一个KIR2DL1-HLA-Cw4晶体中观察到了KIR-HLA-C复合物的二聚体聚集体。人类和黑猩猩具有HLA-C特异性的KIR之间不同的大多数氨基酸在KIR-HLA界面之外形成溶剂可及的簇,这表明KIR存在未被发现的相互作用。

相似文献

1
Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex.人类自然杀伤细胞抑制性受体KIR2DL1-HLA-Cw4复合物的晶体结构
Nat Immunol. 2001 May;2(5):452-60. doi: 10.1038/87766.
2
Natural killer cell recognition of HLA class I molecules.自然杀伤细胞对HLA I类分子的识别。
Rev Immunogenet. 2000;2(3):433-48.
3
Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand.自然杀伤细胞免疫球蛋白样受体与其I类主要组织相容性复合体配体复合物的晶体结构。
Nature. 2000 Jun 1;405(6786):537-43. doi: 10.1038/35014520.
4
A disulfide-linked natural killer cell receptor dimer has higher affinity for HLA-C than wild-type monomer.一种二硫键连接的自然杀伤细胞受体二聚体对HLA - C的亲和力高于野生型单体。
Eur J Immunol. 2000 Sep;30(9):2692-7. doi: 10.1002/1521-4141(200009)30:9<2692::AID-IMMU2692>3.0.CO;2-0.
5
Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.自然杀伤细胞抑制性受体的直接结合与功能转移揭示了HLA - C同种异型识别的新模式。
J Immunol. 1998 Jul 15;161(2):571-7.
6
A HLA-Cw6 specific single-chain antibody fragment (scFv) recognizing a natural killer cell receptor epitope.一种识别自然杀伤细胞受体表位的HLA - Cw6特异性单链抗体片段(scFv)。
Mol Immunol. 2005 Mar;42(5):643-9. doi: 10.1016/j.molimm.2004.09.013.
7
[Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].[人鼻咽癌细胞系对自然杀伤细胞的免疫编辑:杀伤细胞免疫球蛋白样受体(KIRs)和自然杀伤细胞2D受体(NKG2D)表达改变导致自然杀伤细胞介导的细胞溶解作用降低]
Nan Fang Yi Ke Da Xue Xue Bao. 2007 Mar;27(3):247-9.
8
Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors.p58自然杀伤细胞抑制性受体识别HLA - C的分子基础。
J Immunol. 1997 Oct 15;159(8):3875-82.
9
HLA-Cw4 expression on porcine endothelial cells reduces cytotoxicity and adhesion mediated by CD158a+ human NK cells.猪内皮细胞上的HLA-Cw4表达降低了由CD158a + 人自然杀伤细胞介导的细胞毒性和粘附作用。
Xenotransplantation. 2009 Jan-Feb;16(1):19-26. doi: 10.1111/j.1399-3089.2009.00510.x.
10
Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity.可溶性 HLA-I 介导的人 NK 细胞分泌 TGF-β1,并由此下调抗肿瘤细胞溶解活性。
Eur J Immunol. 2009 Dec;39(12):3459-68. doi: 10.1002/eji.200939728.

引用本文的文献

1
RIFINs displayed on malaria-infected erythrocytes bind KIR2DL1 and KIR2DS1.疟原虫感染的红细胞表面展示的裂殖子表面蛋白(RIFINs)可结合杀伤细胞免疫球蛋白样受体2DL1(KIR2DL1)和杀伤细胞免疫球蛋白样受体2DS1(KIR2DS1)。
Nature. 2025 Jun 11. doi: 10.1038/s41586-025-09091-y.
2
Peptide-specific natural killer cell receptors.肽特异性自然杀伤细胞受体
Oxf Open Immunol. 2025 Apr 17;6(1):iqaf003. doi: 10.1093/oxfimm/iqaf003. eCollection 2025.
3
Recognition of Self and Viral Ligands by NK Cell Receptors.自然杀伤细胞受体对自身和病毒配体的识别。
Immunol Rev. 2025 Jan;329(1):e13435. doi: 10.1111/imr.13435.
4
Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization.自然杀伤细胞功能、信号转导、分子机制及临床应用的综合概述。
Signal Transduct Target Ther. 2024 Nov 8;9(1):302. doi: 10.1038/s41392-024-02005-w.
5
Effect of plasma-induced oxidation on NK cell immune checkpoint ligands: A computational-experimental approach.等离子体诱导氧化对 NK 细胞免疫检查点配体的影响:计算-实验研究方法。
Redox Biol. 2024 Nov;77:103381. doi: 10.1016/j.redox.2024.103381. Epub 2024 Oct 1.
6
Structural basis for the activity and specificity of the immune checkpoint inhibitor lirilumab.免疫检查点抑制剂 lirilumab 的活性和特异性的结构基础。
Sci Rep. 2024 Jan 7;14(1):742. doi: 10.1038/s41598-023-50262-6.
7
Bw4 ligand and direct T-cell receptor binding induced selection on HLA A and B alleles.Bw4 配体和直接 T 细胞受体结合诱导 HLA A 和 B 等位基因的选择。
Front Immunol. 2023 Nov 21;14:1236080. doi: 10.3389/fimmu.2023.1236080. eCollection 2023.
8
Innate immune cellular therapeutics in transplantation.移植中的固有免疫细胞疗法。
Front Transplant. 2023;2. doi: 10.3389/frtra.2023.1067512. Epub 2023 Mar 31.
9
HLA-DPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVID-19.HLA-DPB1*13:01 与重症 COVID-19 发病的增强保护相关,而 KIR2DS4*001 与保护作用减弱相关。
HLA. 2024 Jan;103(1):e15251. doi: 10.1111/tan.15251. Epub 2023 Oct 18.
10
Non-Classical HLA Class 1b and Hepatocellular Carcinoma.非经典HLA I类分子b与肝细胞癌
Biomedicines. 2023 Jun 9;11(6):1672. doi: 10.3390/biomedicines11061672.